MEDP vs. CPRX
MEDP (Medpace Holdings, Inc.) and CPRX (Catalyst Pharmaceuticals, Inc.) are both stocks. Both are in the Healthcare sector — MEDP in Diagnostics & Research, CPRX in Biotechnology. Over the past 5 years, MEDP returned 26.82%/yr vs 41.46%/yr for CPRX. Their 0.28 correlation means their historical movements had little consistent relationship.
Performance
MEDP vs. CPRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MEDP achieves a 2.75% return, which is significantly lower than CPRX's 34.92% return.
MEDP
- 1D
- -0.21%
- 1M
- 3.50%
- 6M
- -0.92%
- YTD
- 2.75%
- 1Y
- 36.40%
- 3Y*
- 31.18%
- 5Y*
- 26.82%
- 10Y*
- —
- ALL TIME*
- 35.39%
CPRX
- 1D
- 0.00%
- 1M
- 0.13%
- 6M
- 29.59%
- YTD
- 34.92%
- 1Y
- 49.10%
- 3Y*
- 32.72%
- 5Y*
- 41.46%
- 10Y*
- 44.91%
- ALL TIME*
- 8.79%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $292.94M | $222.04M | $171.72M |
MEDP vs. CPRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MEDP Medpace Holdings, Inc. | 2.75% | 69.05% | 8.38% | 44.31% | -2.40% | 56.35% | 65.60% | 58.81% | 45.97% | 0.53% |
CPRX Catalyst Pharmaceuticals, Inc. | 34.92% | 11.84% | 24.15% | -9.62% | 174.74% | 102.69% | -10.93% | 95.31% | -50.90% | 272.38% |
Correlation
The correlation between MEDP and CPRX is 0.23, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.23 |
Correlation (3Y) Balances recent behavior with more history. | 0.28 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.34 |
Correlation (All Time) Calculated using the full available price history since Aug 11, 2016 | 0.28 |
The correlation between MEDP and CPRX shifts across timeframes, from 0.23 (1 year) to 0.34 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
MEDP:
$16.11B
CPRX:
$3.85B
MEDP:
$16.89
CPRX:
$1.74
MEDP:
34.17
CPRX:
18.08
MEDP:
1.03
CPRX:
0.32
MEDP:
6.04
CPRX:
6.70
MEDP:
38.26
CPRX:
3.95
MEDP:
$2.78B
CPRX:
$596.96M
MEDP:
$800.22M
CPRX:
$378.23M
MEDP:
$613.10M
CPRX:
$313.50M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MEDP vs. CPRX — Risk / Return Rank
MEDP
CPRX
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
MEDP vs. CPRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Medpace Holdings, Inc. (MEDP) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MEDP | CPRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.75 | ||
| Sortino ratioReturn per unit of downside risk | -0.93 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.31 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 0.96 | 3.52 | -2.55 |
| Martin ratioReturn relative to average drawdown | 2.04 | 9.42 | -7.38 |
Loading charts...
Drawdowns
MEDP vs. CPRX - Drawdown Comparison
The maximum MEDP drawdown since its inception was -42.87%, smaller than the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for MEDP and CPRX.
Loading charts...
Drawdown Indicators
| MEDP | CPRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -42.87% | -94.25% | +51.38% |
Max Drawdown (1Y)Largest decline over 1 year | -36.61% | -13.91% | -22.70% |
Max Drawdown (3Y)Largest decline over 3 years | -39.38% | -27.29% | -12.09% |
Max Drawdown (5Y)Largest decline over 5 years | -42.87% | -45.37% | +2.50% |
Max Drawdown (10Y)Largest decline over 10 years | — | -64.87% | — |
Current DrawdownCurrent decline from peak | -7.01% | -0.03% | -6.98% |
Average DrawdownAverage peak-to-trough decline | -12.94% | -51.73% | +38.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.24% | 5.18% | +12.06% |
Volatility
MEDP vs. CPRX - Volatility Comparison
Medpace Holdings, Inc. (MEDP) has a higher volatility of 16.14% compared to Catalyst Pharmaceuticals, Inc. (CPRX) at 0.41%. This indicates that MEDP's price experiences larger fluctuations and is considered to be riskier than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MEDP | CPRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.14% | 0.41% | +15.73% |
Volatility (6M)Calculated over the trailing 6-month period | 41.25% | 21.80% | +19.45% |
Volatility (1Y)Calculated over the trailing 1-year period | 44.64% | 31.77% | +12.87% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 52.09% | 47.65% | +4.44% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.81% | 59.86% | -10.05% |
Dividends
MEDP vs. CPRX - Dividend Comparison
Neither MEDP nor CPRX has paid dividends to shareholders.
Financials
MEDP vs. CPRX - Financials Comparison
This section allows you to compare key financial metrics between Medpace Holdings, Inc. and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MEDP vs. CPRX - Profitability Comparison
MEDP - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Medpace Holdings, Inc. reported a gross profit of 201.64M and revenue of 707.33M. Therefore, the gross margin over that period was 28.5%.
CPRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Catalyst Pharmaceuticals, Inc. reported a gross profit of 0.00 and revenue of 149.39M. Therefore, the gross margin over that period was 0.0%.
MEDP - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Medpace Holdings, Inc. reported an operating income of 146.82M and revenue of 707.33M, resulting in an operating margin of 20.8%.
CPRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Catalyst Pharmaceuticals, Inc. reported an operating income of 73.23M and revenue of 149.39M, resulting in an operating margin of 49.0%.
MEDP - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Medpace Holdings, Inc. reported a net income of 121.36M and revenue of 707.33M, resulting in a net margin of 17.2%.
CPRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Catalyst Pharmaceuticals, Inc. reported a net income of 63.73M and revenue of 149.39M, resulting in a net margin of 42.7%.
Frequently Asked Questions
MEDP and CPRX have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MEDP has higher volatility (16.14%) compared to CPRX (0.41%). In terms of maximum drawdown, MEDP dropped -42.87% vs CPRX's -94.25%.
CPRX currently has the higher Sharpe Ratio (1.54 vs 0.79), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MEDP and CPRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer